Insider 10b5-1 Sales Reported by Alexis Lequoc

Alexis T. Lequoc reported proposed and completed sales of Class A Common shares under a 10b5-1 plan.

Rhea-AI Filing Summary

Alexis T. Lequoc reported proposed and completed sales of Class A Common shares under a 10b5-1 plan. The filing lists multiple disposals in April–June 2026 and a planned exercise-based sale on 07/08/2026. Several prior option exercises on 12/06/2023 are also recorded.

Insights

Corporate Governance Analyst

Routine 10b5-1 insider disposals across spring 2026; exercises noted.

The filing records multiple 10b5-1 sales by Alexis T. Lequoc in Apr–Jun 2026 and a scheduled exercise-related sale on 07/08/2026. The entries list share counts and gross proceeds for each trade.

Cash flows and post-transaction holdings are not shown in the excerpt; subsequent SEC filings may provide updated position details.

Key Figures

Sale on 06/22/2026: 43,224 shares Sale on 06/01/2026: 43,224 shares Sale on 06/02/2026: 21,506 shares +3 more

6 metrics

Sale on 06/22/2026 43,224 shares 10b5-1 sale, gross proceeds $9,551,315.34

Sale on 06/01/2026 43,224 shares 10b5-1 sale, gross proceeds $11,715,649.08

Sale on 06/02/2026 21,506 shares 10b5-1 sale, gross proceeds $5,745,422.53

Planned exercise-based sale 10,688 shares Exercise of stock options dated 07/08/2026, cash transaction

Prior option exercise 43,224 shares Previously exercised stock options dated 12/06/2023, cash transaction

Sale on 05/04/2026 (two tranches) 43,224 shares; 10,688 shares 10b5-1 sales, gross proceeds $4,698,507.15 and $1,549,025.73 respectively

Key Terms

10b5-1, Exercise of Stock Options, Gross proceeds

3 terms

10b5-1 regulatory

"10b5-1 Sales for ALEXIS T LEQUOC 620 8th Avenue"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Exercise of Stock Options financial

"Class A Common | 07/08/2026 | Exercise of Stock Options"

Gross proceeds financial

"43224 | 11715649.08"

The total amount of cash a company receives from a financing event or sale before any fees, expenses, taxes or deductions are taken out. Investors watch gross proceeds because it shows the raw scale of new capital being raised—think of it as the paycheck amount before withholdings—which helps assess how much funding is available for operations, growth, debt payoff or how much shareholder dilution might occur once costs are removed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What sales does the DDOG Form 144 list for Alexis T. Lequoc?

It lists multiple 10b5-1 sales of Class A Common shares in April–June 2026. The excerpt shows discrete transactions on 04/22/2026, 05/04/2026, 05/05/2026, 05/18/2026, 06/01/2026, 06/02/2026, and 06/22/2026, each with share counts and gross proceeds.

How many shares were sold on 06/22/2026 and what proceeds were reported?

On 06/22/2026 the filing shows 43,224 shares sold for $9,551,315.34. That line item is presented as a 10b5-1 sale by Alexis T. Lequoc and reports the aggregate gross proceeds for that transaction.

Does the filing show any option exercises related to these sales?

Yes. The excerpt records an exercise-related sale of 10,688 shares dated 07/08/2026 and prior exercised options of 43,224 shares on 12/06/2023. Those lines are labeled as exercises of stock options and show associated dates and share counts.

Were the reported sales made under a trading plan?

The transactions are labeled as 10b5-1 sales in the excerpt. The entries explicitly identify those disposals as 10b5-1 sales, indicating they were executed under a pre-established trading plan rather than ad hoc open-market trades.

Does the Form 144 disclose proceeds treatment or post-sale holdings?

The excerpt lists gross proceeds per transaction but does not state who receives proceeds or post-transaction holdings. The filing rows show aggregate proceeds figures for each sale; cash-flow recipients and updated ownership amounts are not included in the provided text.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/08/2026 - 04:38 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001783984
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Datadog, Inc.
SEC File Number	001-39051
Address of Issuer	620 8th Avenue, 45th Floor New York NEW YORK 10018
Phone	8663294466
Name of Person for Whose Account the Securities are To Be Sold	ALEXIS T LEQUOC
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	53912	13845140.72	330825798	07/08/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common	07/08/2026	Exercise of Stock Options	Issuer			10688	07/08/2026	Cash
Class A Common	12/06/2023	Previously Exercised Stock Options	Issuer			43224	12/06/2023	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for ALEXIS T LEQUOC 620 8th Avenue, 45th Floor New York NY 10018	Class A Common	06/22/2026	43224	9551315.34
ALEXIS T LEQUOC 620 8th Avenue, 45th Floor New York NY 10018	Class A Common	06/02/2026	21506	5745422.53
10b5-1 Sales for ALEXIS T LEQUOC 620 8th Avenue, 45th Floor New York NY 10018	Class A Common	06/01/2026	43224	11715649.08
10b5-1 Sales for ALEXIS T LEQUOC 620 8th Avenue, 45th Floor New York NY 10018	Class A Common	06/01/2026	10688	2896928.96
10b5-1 Sales for ALEXIS T LEQUOC 620 8th Avenue, 45th Floor New York NY 10018	Class A Common	05/18/2026	43224	8992459.28
10b5-1 Sales for ALEXIS T LEQUOC 620 8th Avenue, 45th Floor New York NY 10018	Class A Common	05/05/2026	10806	1620900.00
10b5-1 Sales for ALEXIS T LEQUOC 620 8th Avenue, 45th Floor New York NY 10018	Class A Common	05/04/2026	32418	4698507.15
10b5-1 Sales for ALEXIS T LEQUOC 620 8th Avenue, 45th Floor New York NY 10018	Class A Common	05/04/2026	10688	1549025.73
10b5-1 Sales for ALEXIS T LEQUOC 620 8th Avenue, 45th Floor New York NY 10018	Class A Common	04/22/2026	43224	5655315.78

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the previous exercise of stock options during the period of 12/06/2023 through 10/14/2024. Securities to be sold, acquired through RSU/PSU or upon option exercise, were registered on Form S-8.
Date of Notice	07/08/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/13/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Alexis Le-Quoc
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)